Hadassah

Hadassah Drug to Fight Fatty Liver Disease Progressing Well in US Clinical Trials

Thursday, Sep 3 2015

Clinical trials with a Hadassah-developed technology to treat fatty liver disease are moving forward in 25 medical centers, in the United States and Australia. Fatty liver disease, in its severe form—called non-alcoholic steatohepatitis (NASH)—can lead to cirrhosis and liver cancer and there are currently no other treatments available.

Among the US test sites are the Cleveland Clinic (Ohio), Duke Liver Center (Durham, NC), Baylor St. Luke's Medical Center (Houston, Tex), and University of Virginia (Charlottesville). The Australian sites include Westmead Hospital (Sydney) and The Alfred (Melbourne).

Hadasit, Hadassah’s technology transfer arm, and Immuron, an Australian biopharmaceutical company, worked together to develop the product, being referred to as IMM-124E. The collaborative effort combines Hadassah’s oral immune modulation approach with antibodies produced by Immuron. See http://www.hadassah.org/news-stories/fda-grants-approval-for-us.html

Immuron has also announced that it is beginning a United States Investor Roadshow, where it will showcase its technology platform and profile to US investment groups. The company reports that its clinical trials “are progressing well” and that “a recent Deutsche Bank review of the NASH market suggests that there is a worldwide market for NASH of between $35-40 billion.” The company further explains that “the high prevalence of Type 2 diabetes and obesity, which leads to NASH and other non-alcoholic fatty liver diseases, boosts the prevalence of NASH and its market growth.”

View the Roadshow presentation: http://www.immuron.com/index.php/download_file/-/view/142/

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Jul 11 2019

Breakthrough at Hadassah Hospital in Correcting Scoliosis for Special-Needs Teen

Spine specialists at Hadassah Hospital Ein Kerem used an innovative, minimally invasive approach to correct scoliosis in a 14-year-old with Down syndrome.

READ MORE ›
alt_text

Thursday, Jul 11 2019

Hadassah Doctors Give a Gazan Patient With an Incurable Skin Disease a “Normal Life”

Pioneering treatment by physicians at Hadassah Hospital Ein Kerem is giving a Gazan man who suffers from...

READ MORE ›
alt_text

Tuesday, Jul 2 2019

“Just Clownin’ Around!” Medical Clown at Hadassah Hospital Turns Tears Into Laughter

Clowns aren't just at circuses anymore! At Hadassah Hospital in Jerusalem, clowns, working as part of the medical team, bring smiles to the faces of sick patients—children and adults alike—every day.

READ MORE ›
alt_text

Tuesday, Jul 2 2019

The School That Helps You Forget Your Cancer

With her eyes sparkling with excitement, five-year-old Osher Tubiyan said goodbye to Hadassah's hospitalized children’s school after eight months of successfully struggling with leukemia.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More